Eli Lilly Shares Surge 10% on Blockbuster Earnings, Fueled by Obesity Drug Dominance
The pharmaceutical giant added nearly $100 billion to its market capitalization following a stellar quarterly report, driven by soaring demand for its GLP-1 drugs Mounjaro and Zepbound.